HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential expression of chemokines, chemokine receptors, cytokines and cytokine receptors in diffuse large B cell malignant lymphoma.

Abstract
Host immunity, particularly T cell immunity (Th1/Th2 balance), plays an important role in clinicopathological features of malignant disease. However, the T cell immunity has not been fully investigated in patients with lymphoid malignancies. Recent studies suggested the important role of dysregulation of the endogenous immune system in lymphomagenesis. The relationships between cytokines/chemokines and their receptors, are important in determining the selectivity of local immunity. To investigate differences in the endogenous immune system of diffuse large B cell lymphoma (DLBL), we performed gene expression profiling using cDNA microarrays of cytokines/chemokines and their receptors. We studied 5 cases each of primary central nervous system lymphomas (PCNSL), extranodal and nodal lymphomas. PCNSL exhibited diffuse down-regulated profiles, compared to normal peripheral blood lymphocytes. While extranodal and nodal lymphomas also exhibited diffuse down-regulated profiles, some genes displayed up-regulated profiles. Hierarchical clustering analysis separated PCNSL and extranodal lymphomas into distinct groups based on their gene expression profiles, as well as extranodal and nodal, but not PCNSL and nodal. PCNSL exhibited significantly lower expression of BLC/BCA-1 and CCR-3 (Th2 type), and higher expression of IL-8 and MIP-1beta (Th1 type) than extranodal lymphomas. Immunohistochemistry and RT-PCR revealed frequent CCR-3 and BLC/BCA-1 expression in extranodal lymphomas, compared with PCNSL. Our results provide new insights into the pathogenesis of each DLBL. A better understanding of the immune response in each DLBL could help in the design of novel therapeutic strategies based on cytokines/chemokines and their receptors.
AuthorsAkira Fujii, Koichi Ohshima, Makoto Hamasaki, Yoshifumi Makimoto, Seiji Haraoka, Hidetsuna Utsunomiya, Masatoshi Okazaki, Masahiro Kikuchi
JournalInternational journal of oncology (Int J Oncol) Vol. 24 Issue 3 Pg. 529-38 (Mar 2004) ISSN: 1019-6439 [Print] Greece
PMID14767537 (Publication Type: Journal Article)
Chemical References
  • CCR3 protein, human
  • CXCL13 protein, human
  • Chemokine CXCL13
  • Chemokines
  • Chemokines, CXC
  • Cytokines
  • DNA, Complementary
  • Receptors, CCR3
  • Receptors, Chemokine
  • Receptors, Cytokine
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Chemokine CXCL13
  • Chemokines (biosynthesis)
  • Chemokines, CXC (biosynthesis)
  • Cytokines (biosynthesis)
  • DNA, Complementary (metabolism)
  • Down-Regulation
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunohistochemistry
  • Lymphocytes (metabolism)
  • Lymphoma, Large B-Cell, Diffuse (metabolism)
  • Male
  • Middle Aged
  • Multigene Family
  • Oligonucleotide Array Sequence Analysis
  • Receptors, CCR3
  • Receptors, Chemokine (biosynthesis)
  • Receptors, Cytokine (biosynthesis)
  • Reverse Transcriptase Polymerase Chain Reaction
  • T-Lymphocytes (metabolism)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: